Appeals Court Probes Louisiana Bid to Roll Back Telemedicine Access to Mifepristone
A three-judge panel of the U.S. Court of Appeals for the 5th Circuit expressed skepticism about Louisiana's request to invalidate a 2023 FDA rule that permits mifepristone to be prescribed by telemedicine and mailed nationwide. Judges raised doubts about whether the state can show the rule directly causes the abortions it cites and noted prior Supr…